9616 Stock Overview
Engages in the imports and supplies medical devices and medical equipment in the Kingdom of Saudi Arabia. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Jana Medical Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ر.س42.75 |
52 Week High | ر.س45.00 |
52 Week Low | ر.س34.40 |
Beta | 0 |
1 Month Change | 0.83% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 17.45% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
9616 | SA Healthcare | SA Market | |
---|---|---|---|
7D | 4.3% | -0.2% | 1.2% |
1Y | n/a | -2.4% | -7.1% |
Return vs Industry: Insufficient data to determine how 9616 performed against the SA Healthcare industry.
Return vs Market: Insufficient data to determine how 9616 performed against the SA Market.
Price Volatility
9616 volatility | |
---|---|
9616 Average Weekly Movement | 5.2% |
Healthcare Industry Average Movement | 4.8% |
Market Average Movement | 3.7% |
10% most volatile stocks in SA Market | 7.9% |
10% least volatile stocks in SA Market | 2.1% |
Stable Share Price: 9616 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: Insufficient data to determine 9616's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Jamil Muthib Al-Otaibi | www.janamd.com.sa |
Jana Medical Company, together with its subsidiaries, engages in the imports and supplies medical devices and medical equipment in the Kingdom of Saudi Arabia. The company also manufactures medical devices. It supplies medical and devices for anesthesia, neurosurgery, spine, ear, nose, throat, and other surgeries.
Jana Medical Company Fundamentals Summary
9616 fundamental statistics | |
---|---|
Market cap | ر.س136.37m |
Earnings (TTM) | ر.س0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 9616 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9616 income statement (TTM) | |
---|---|
Revenue | ر.س0 |
Cost of Revenue | ر.س0 |
Gross Profit | ر.س0 |
Other Expenses | ر.س0 |
Earnings | ر.س0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 9616 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/19 14:16 |
End of Day Share Price | 2025/01/19 00:00 |
Earnings | N/A |
Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jana Medical Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|